Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	June 30, 2020	High Trail	Asset Purchase Agreement	Common Stock	Common Stock June 30, 2020	Common Stock March 12, 2020	Common Stock High Trail	Common Stock Asset Purchase Agreement	Additional Paid-in Capital	Additional Paid-in Capital High Trail	Additional Paid-in Capital Asset Purchase Agreement	Retained Earnings	AOCI Attributable to Parent
Beginning balance at Dec. 31, 2020	$ 23,382				$ 3					$ 216,305			$ (192,935)	$ 9
Beginning balance, shares at Dec. 31, 2020					27,074,791
Net loss	(118,859)												(118,859)
Issuance of common stock upon exercise of stock option grants	8,749									8,749
Issuance of common stock upon exercise of stock option grants, shares					978,495
Issuance of common stock related to exercise of warrants	40,284									40,284
Issuance of common stock related to exercise of warrants, shares					1,047,140
Issuance of common stock in connection with acquisition of Healing Solutions assets	39,454									39,454
Issuance of common stock in connection with acquisition of Healing Solutions assets, shares					1,387,759
Issuance of restricted stock awards	3,370									3,370
Issuance of restricted stock awards, shares					108,696
Issuance of warrants to High Trail	39,016									39,016
Issuance of common stock	36,735		$ 4,056	$ 11,075						36,735	$ 4,056	$ 11,075
Issuance of common stock, shares					2,666,667			130,000	704,548
Reclassification of warrants to equity	80,022									80,022
Issuance of restricted common stock, shares					1,895,642
Forfeiture of restricted common stock, shares					(258,971)
Stock-based compensation expense	8,539									8,539
Other comprehensive loss	(46)													(46)
Ending balance at Jun. 30, 2021	175,777				$ 3					487,605			(311,794)	(37)
Ending balance, shares at Jun. 30, 2021					35,734,767
Issuance of warrants in connection with offering	(80,022)									(80,022)
Beginning balance at Mar. 31, 2021	38,465				$ 3					313,911			(275,488)	39
Beginning balance, shares at Mar. 31, 2021					30,590,796
Net loss	(36,306)												(36,306)
Issuance of common stock related to exercise of warrants	112									112
Issuance of common stock related to exercise of warrants, shares					7,180
Issuance of warrants to High Trail	39,016									39,016
Issuance of common stock	36,735		$ 4,056	$ 11,075						36,735	$ 4,056	$ 11,075
Issuance of common stock, shares					2,666,667			130,000	704,548
Reclassification of warrants to equity	80,022									80,022
Issuance of restricted common stock, shares					1,895,642
Forfeiture of restricted common stock, shares					(258,971)
Cancellation of RSU issued to consultant	(57)									(57)
Cancellation of RSU issued to consultant, shares					(1,095)
Stock-based compensation expense	2,735									2,735
Other comprehensive loss	(76)													(76)
Ending balance at Jun. 30, 2021	175,777				$ 3					487,605			(311,794)	(37)
Ending balance, shares at Jun. 30, 2021					35,734,767
Issuance of warrants in connection with offering	(80,022)									(80,022)
Beginning balance at Dec. 31, 2021	224,228				$ 5					653,650			(428,959)	(468)
Beginning balance, shares at Dec. 31, 2021					55,090,237
Net loss	(59,085)												(59,085)
Issuance of common stock	27,007				$ 1					27,006
Issuance of common stock, shares					7,003,332
Reclassification of warrants to equity	18,982									18,982
Issuance of restricted common stock, shares		$ 1				$ 1
Issuance of restricted common stock, shares						4,020,674
Forfeiture of restricted common stock, shares							(201,596)
Exercise of Prefunded Warrants	15,039									15,039
Exercise of Prefunded Warrants, shares					3,013,850
Issuance of common stock for settlement of seller note	767									767
Issuance of common stock for settlement of seller note, shares					292,887
Loss on initial issuance of equity	5,835									5,835
Issuance of warrants to contractors	1,137									1,137
Stock-based compensation expense	5,503									5,503
Other comprehensive loss	(602)													(602)
Ending balance at Jun. 30, 2022	200,848				$ 7					689,955			(488,044)	(1,070)
Ending balance, shares at Jun. 30, 2022					69,219,384
Issuance of warrants in connection with offering	(18,982)									(18,982)
Beginning balance at Mar. 31, 2022	197,352				$ 6					669,720			(471,735)	(639)
Beginning balance, shares at Mar. 31, 2022					62,348,318
Net loss	(16,309)												(16,309)
Issuance of restricted common stock, shares		$ 1				$ 1
Issuance of restricted common stock, shares						3,865,218
Forfeiture of restricted common stock, shares						(8,002)
Exercise of Prefunded Warrants	15,039									15,039
Exercise of Prefunded Warrants, shares					3,013,850
Issuance of warrants to contractors	1,137									1,137
Stock-based compensation expense	4,059									4,059
Other comprehensive loss	(431)													(431)
Ending balance at Jun. 30, 2022	$ 200,848				$ 7					$ 689,955			$ (488,044)	$ (1,070)
Ending balance, shares at Jun. 30, 2022					69,219,384